Publications

Showing entries 41 - 60 out of 108

2018

Carboni S, Zucca A, Stoccoro S, Maiore L, Arca M, Ortu F et al. New Variations on the Theme of Gold(III) C ∧ N ∧ N Cyclometalated Complexes as Anticancer Agents: Synthesis and Biological Characterization. Inorganic Chemistry. 2018 Dec 3;57(23):14852-14865. doi: 10.1021/acs.inorgchem.8b02604
Klose MHM, Theiner S, Varbanov HP, Hoefer D, Pichler V, Galanski MS et al. Development and Validation of Liquid Chromatography-Based Methods to Assess the Lipophilicity of Cytotoxic Platinum(IV) Complexes. In Contel M, editor, Unconventional Anticancer Metallodrugs and Strategies to Improve their Pharmacological Profile. 4 ed. Vol. 6. Basel: Multi-disciplinary digital publishing institute (MDPI). 2018. p. 71-84. 130. (Inorganics). doi: 10.3390/inorganics6040130
Klose MHM, Schöberl A, Heffeter P, Berger W, Hartinger CG, Koellensperger G et al. Serum-binding properties of isosteric ruthenium and osmium anticancer agents elucidated by SEC-ICP-MS. Monatshefte für Chemie. 2018 Oct;149(10):1719-1726. doi: 10.1007/s00706-018-2280-1
Aikman B, de Almeida A, Meier-Menches SM, Casini A. Aquaporins in cancer development: opportunities for bioinorganic chemistry to contribute novel chemical probes and therapeutic agents. Metallomics: integrated biometal science. 2018 May 1;10(5):696-712. doi: 10.1039/c8mt00072g
Muqaku B, Eisinger M, Meier-Menches SM, Tahir A, Pukrop T, Haferkamp S et al. Reprogramming of organ functions via systemic calcium mobilization. In Book of Abstracts. 2018
Babak MV, Pfaffeneder-Kmen M, Meier-Menches SM, Legina MS, Theiner S, Licona C et al. Rollover Cyclometalated Bipyridine Platinum Complexes as Potent Anticancer Agents: Impact of the Ancillary Ligands on the Mode of Action. Inorganic Chemistry. 2018 Mar 5;57(5):2851-2864. doi: 10.1021/acs.inorgchem.7b03210
Klose MHM, Theiner S, Kornauth C, Meier-Menches SM, Heffeter P, Berger W et al. Bioimaging of isosteric osmium and ruthenium anticancer agents by LA-ICP-MS. Metallomics: integrated biometal science. 2018 Mar 1;10(3):388-396. doi: 10.1039/c8mt00012c
Meier-Menches SM, Gerner C, Berger W, Hartinger CG, Keppler BK. Structure-activity relationships for ruthenium and osmium anticancer agents - towards clinical development. Chemical Society Reviews. 2018 Feb 7;47(3):909-928. doi: 10.1039/c7cs00332c
Mayer RL, Schwarzmeier JD, Gerner MC, Bileck A, Mader JC, Meier-Menches SM et al. Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia. Molecular and Cellular Proteomics. 2018 Feb;17(2):290-303. UNSP RA117.000425. doi: 10.1074/mcp.RA117.000425

2017

Artner C, Holtkamp HU, Hartinger CG, Meier-Menches SM. Characterizing activation mechanisms and binding preferences of ruthenium metallo-prodrugs by a competitive binding assay. Journal of Inorganic Biochemistry. 2017 Dec;177:322-327. doi: 10.1016/j.jinorgbio.2017.07.010
Aust S, Bachmayr-Heyda A, Auer K, Meier-Menches SM, Schmetterer K, Dekan S et al. IMPACT ON SURVIVAL OF INTEGRATIVE SYSTEMIC AND LOCAL METABOLOMICS IN HIGH-GRADE SEROUS OVARIAN CANCER. International Journal of Gynecological Cancer. 2017 Nov;27( Supplement 4 ):335-335. ESGO7-1011. doi: 10.1097/01.IGC.0000527296.86225.87
Reichle A, Muqaku B, Eisinger M, Meier SM, Tahir A, Pukrop T et al. Multi-omics analysis of serum samples demonstrates reprogramming of organ functions via systemic calcium mobilization and platelet activation in metastatic melanoma. Oncology Research and Treatment. 2017 Sept;40:191-191.
Gerner C, Meier SM, Kreutz D, Weiss T, Bileck A, Keppler B et al. On the molecular mechanism of action of organometallic anticancer drugs. In Book of Abstracts. 2017
Artner C, Holtkamp HU, Kandioller W, Hartinger CG, Meier SM, Keppler BK. DNA or protein? Capillary zone electrophoresismass spectrometry rapidly elucidates metallodrug binding selectivity. Chemical Communications. 2017 Jul 21;53(57):8002-8005. doi: 10.1039/c7cc04582d
Klose MHM, Hejl M, Heffeter P, Jakupec MA, Meier SM, Berger W et al. Post-digestion stabilization of osmium enables quantification by ICP-MS in cell culture and tissue. The Analyst. 2017 Jul 7;142(13):2327-2332. doi: 10.1039/c7an00350a
Meier SM, Kreutz D, Winter L, Klose MHM, Cseh K, Weiss T et al. An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin. Angewandte Chemie (International Edition). 2017 Jul 3;56(28):8267-8271. doi: 10.1002/anie.201702242
Hanif M, Meier SM, Adhireksan Z, Henke H, Martic S, Movassaghi S et al. Functionalization of ruthenium(II)(ų 6-p-cymene)(3-hydroxy-2-pyridone) complexes with (thio)morpholine: Synthesis and Bioanalytical Studies. Chempluschem. 2017 Jun;82(6):841-847. doi: 10.1002/cplu.201700050
Hochkogler CM, Lieder B, Rust P, Berry D, Meier SM, Pignitter M et al. A 12-week intervention with nonivamide, a TRPV1 agonist, prevents a dietary-induced body fat gain and increases peripheral serotonin in moderately overweight subjects. Molecular Nutrition & Food Research. 2017 May;61(5):1600731. doi: 10.1002/mnfr.201600731
Bachmayr-Heyda A, Aust S, Auer K, Meier SM, Schmetterer KG, Dekan S et al. Integrative Systemic and Local Metabolomics with Impact on Survival in High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 2017 Apr 15;23(8):2081-2092. doi: 10.1158/1078-0432.CCR-16-1647
Sommerfeld NS, Hejl M, Klose MHM, Schreiber-Brynzak E, Bileck A, Meier SM et al. Low-Generation Polyamidoamine Dendrimers as Drug Carriers for Platinum(IV) Complexes. European Journal of Inorganic Chemistry. 2017 Mar 27;2017(12):1713-1720. doi: 10.1002/ejic.201601205
Showing entries 41 - 60 out of 108